MRI Differentiating Gut TB and Crohn's
Differentiating Gut Tuberculosis and Crohn's Disease Via Magnetic Resonance Enterography
1 other identifier
observational
120
1 country
1
Brief Summary
It is clinically challenging to differentiate Crohn's disease from gut tuberculosis especially in regions endemic of tuberculosis infection. The investigators plan to perform magnetic resonance enterography (MRE) who presented to our hospital in Shenzhen, China for new onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy. MRE findings will be independently interpreted by two radiologistsThe role of MRE in distinguishing gut tuberculosis from Crohn's disease will be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2014
CompletedFirst Submitted
Initial submission to the registry
March 15, 2017
CompletedFirst Posted
Study publicly available on registry
March 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedApril 17, 2019
April 1, 2019
4 years
March 15, 2017
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Small / large bowel transmural enhancement
Via magnetic resonance enterography independently interpreted by two radiologist with expertise
During procedure
Secondary Outcomes (3)
Skip lesions in small / large bowel
During procedure
Vascular engorgement
During procedure
Mesenteric combing
During procedure
Study Arms (1)
Magnetic resonance imaging
Patients with new-onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.
Interventions
Enterography performed via magnetic resonance imaging
Eligibility Criteria
Consecutive patients with new-onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.
You may qualify if:
- New-onset lower gastrointestinal symptoms of less than 3 months
- Ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.
- No prior tuberculosis treatment
- No prior immunomodulatory or anti-tumor necrosis factor treatment
You may not qualify if:
- Stage 4 or 5 chronic kidney disease, i.e. a glomerular filtration rate of \<=30 ml/min.
- Contraindications to magnetic resonance imaging, including the installation of metallic devices or implants in-situ (e.g. pacemakers)
- Prior intestinal resection
- Known concomitant chronic small / large bowel disease, including ulcerative colitis, eosinophilic gastroenteritis, NSAID-related enterography etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Hong Kong-Shenzhen Hospital
Shenzhen, Guangdong, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wai-Kay Seto, MD
The University of Hong Kong-Shenzhen Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
March 15, 2017
First Posted
March 30, 2017
Study Start
December 30, 2014
Primary Completion
December 30, 2018
Study Completion
March 30, 2019
Last Updated
April 17, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share